Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 4Active not recruiting 3Terminated 2Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 27Neoplasm Metastasis 9Stomach Neoplasms 7Ovarian Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Endometrial Neoplasms 3Sarcoma 2Salivary Gland Neoplasms 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2HER2-positive Gastric Cancer 2Carcinoma, Renal Cell 2Brain Neoplasms 2Advanced Solid Tumor 2Advanced Breast Cancer 2Adenocarcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unresectable Locally Recurrent Breast Cancer 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1

Interventions

pembrolizumab 115Carboplatin 103Pemetrexed 90Cisplatin 58Paclitaxel 47osimertinib 41Drug Therapy 40Nivolumab 39Docetaxel 35Specimen Handling 33Magnetic Resonance Spectroscopy 28Bevacizumab 26durvalumab 23Gemcitabine 22cemiplimab 21Radiotherapy 20130-nm albumin-bound paclitaxel 20Radiosurgery 19tislelizumab 18atezolizumab 17aflutinib 15Cetuximab 15Immunotherapy 14Immune Checkpoint Inhibitors 14Platinum Compounds 13Ipilimumab 13Biopsy 12Standard of Care 11Surgical Procedures, Operative 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Non-Small-Cell Lung × trastuzumab deruxtecan × Clear all
NCT07012031 2026-05-13

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

National Cancer Institute (NCI)

Phase 1/2 Recruiting
37 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04686305 2026-04-13

DL03

AstraZeneca

Phase 1 Recruiting
304 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07428044 2026-02-23

HERCULES

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
14 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06899126 2026-01-08

DESTINY-Lung06

Daiichi Sankyo

Phase 3 Recruiting
686 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡